Location History:
- Taipei, TW (2012 - 2014)
- New Taipei, TW (2022 - 2023)
Company Filing History:
Years Active: 2012-2023
Title: Jerry Ting: Innovator in Therapeutic Antibodies
Introduction
Jerry Ting is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, his work focuses on innovative solutions for cancer treatment.
Latest Patents
Among his latest patents, Jerry Ting has disclosed humanized antibodies and antigen-binding fragments that specifically target biantennary Lewis antigens. These antigens are expressed in various cancers, making his inventions crucial for both treatment and detection of these diseases. The disclosed antibodies are designed to target antigen-expressing cells, providing a method for effective treatment. Additionally, he has developed polynucleotides, vectors, and host cells for producing these antibodies and their fragments. His work also includes pharmaceutical compositions and methods for treatment and detection, showcasing the versatility and importance of his inventions.
Career Highlights
Jerry Ting is currently associated with Glyconex, Inc., where he continues to push the boundaries of therapeutic innovations. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.
Collaborations
Jerry has collaborated with notable colleagues, including Tong-Hsuan Chang and Shu-Yen Chang, to further enhance the impact of his research and inventions.
Conclusion
Jerry Ting's contributions to the field of therapeutic antibodies represent a significant advancement in cancer treatment. His innovative work continues to inspire and pave the way for future developments in biotechnology.